MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) financials

MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]

Market Cap: ₹386Cr.
Current Price: ₹284
Stock P/E: 37.5
ROE: 3.78%
ROCE: 5.50%
Book Value: ₹206
Dividend Yield: 0.35%
52W High / Low: ₹454/210

In Jun 2026, MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) reported sales ₹43.85 Cr and net profit ₹2.53 Cr.

Annual TTM: sales ₹184 Cr, net profit ₹10 Cr.

Shareholding: Promoters 40.46% (Jun 2026), FIIs 0.07% (Jun 2026), DIIs 0.40% (Jun 2026), Government 0.05% (Jun 2026), Public 59.01% (Jun 2026).

MEDICAMEQ quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	42.84	41.14	26.00	38.45	42.23	43.49	54.68	43.85
Expenses	36.29	34.90	27.10	34.42	37.18	38.41	50.56	39.07
Operating Profit	6.55	6.24	-1.10	4.03	5.05	5.08	4.12	4.78
OPM %	15.29%	15.17%	-4.23%	10.48%	11.96%	11.68%	7.53%	10.90%
Other Income	0.29	0.14	5.22	0.47	0.37	0.53	1.73	0.86
Interest	1.01	0.73	0.62	0.56	0.84	0.78	0.60	0.64
Depreciation	2.57	2.17	0.47	1.77	1.81	1.75	1.73	1.74
Profit before tax	3.26	3.48	3.03	2.17	2.77	3.08	3.52	3.26
Tax %	30.06%	27.59%	20.79%	24.42%	20.22%	15.58%	15.62%	22.39%
Net Profit	2.27	2.52	2.41	1.64	2.21	2.59	2.97	2.53
EPS in Rs	1.79	1.98	1.90	1.21	1.63	1.91	2.19	1.87
Raw PDF	—	—	—	—	—	—	—	—

MEDICAMEQ profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	117	110	115	138	172	151	179	184
Expenses	99	90	91	113	145	134	159	165
Operating Profit	18	20	24	25	27	17	19	19
OPM %	15%	18%	21%	18%	16%	11%	11%	10%
Other Income	2	1	2	2	2	6	3	3
Interest	1	2	2	3	6	4	4	3
Depreciation	2	3	6	6	7	7	7	7
Profit before tax	17	17	18	17	17	13	12	13
Tax %	26%	25%	18%	13%	21%	26%	19%	—
Net Profit	12	12	15	15	13	9	9	10
EPS in Rs	10.04	10.22	12.20	11.86	10.46	7.43	6.94	7.60
Dividend Payout %	5%	10%	8%	8%	10%	13%	14%	—

MEDICAMEQ balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12	12	12	12	13	13	13	14
Reserves	75	110	122	136	181	196	205	266
Borrowings	12	11	19	26	26	30	27	38
Other Liabilities	38	43	39	52	57	55	48	44
Total Liabilities	137	176	192	226	277	294	293	362
Fixed Assets	24	34	90	92	92	91	86	84
CWIP	15	40	0	0	0	0	0	0
Investments	0	2	2	2	4	8	8	8
Other Assets	97	100	101	131	180	195	199	270
Total Assets	137	176	192	226	277	294	293	362

MEDICAMEQ cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	4	12	13	5	-4	-0	-3	-29
Cash from Investing Activity	-15	-39	-18	-8	-8	-9	-2	-3
Cash from Financing Activity	-4	21	6	4	28	3	-7	60
Net Cash Flow	-14	-6	1	1	17	-6	-11	28
Free Cash Flow	-11	-26	-5	-4	-10	-6	-5	-34
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	48%	88%	87%	33%	-27%	10%	-15%	-151%

MEDICAMEQ shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	42.99%	42.99%	43.16%	40.46%	40.46%	40.46%	40.46%	40.46%
FIIs	0.06%	0.06%	0.12%	0.00%	0.05%	0.02%	0.10%	0.07%
DIIs	1.17%	0.87%	0.69%	0.64%	0.59%	0.44%	0.00%	0.40%
Government	0.00%	0.06%	0.06%	0.05%	0.05%	0.05%	0.05%	0.05%
Public	55.79%	56.04%	55.99%	58.83%	58.84%	59.02%	59.39%	59.01%
No. of Shareholders	10,792	10,576	10,435	10,808	11,177	10,967	10,806	11,047

MEDICAMEQ key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	129	137	165	193	159	102	141	132
Inventory Days	67	85	28	188	230	237	274	258
Days Payable	134	160	161	291	232	152	182	138
Cash Conversion Cycle	62	62	32	91	157	188	234	252
Working Capital Days	116	139	130	146	151	117	186	197
ROCE %	20%	15%	13%	12%	11%	10%	7%	6%

MEDICAMEQUpdated 18 Oct 2026, 15:25

Medicamen Biotech Limited

MEDICAMEQUpdated 18 Oct 2026, 15:25

Market Cap

₹386Cr.

Current Price

₹284

High / Low

₹454/210

Stock P/E

37.5

ROE3.78%

ROCE5.50%

Book Value₹206

Face Value₹10.0

Dividend Yield0.35%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	40.5	0.96	33.09	0.38	1.68	5.15	14.37	4.42	3.49
Sep 2023	42.67	0.91	36.51	0.55	1.8	4	24.75	3.01	2.38
Dec 2023	44.2	0.65	38.61	0.83	1.76	4.01	31.17	2.77	2.19
Mar 2024	45.01	1.87	38.18	0.54	1.77	3.73	16.62	3.1	2.44
Jun 2024	41.48	0.68	36.62	0.58	1.74	3.02	25.17	2.26	1.78
Sep 2024	42.84	1.01	36.29	0.29	2.57	3.26	30.06	2.27	1.79
Dec 2024	41.14	0.73	34.9	0.14	2.17	3.48	27.59	2.52	1.98
Mar 2025	26	0.62	27.1	5.22	0.47	3.03	20.79	2.41	1.9
Jun 2025	38.45	0.56	34.42	0.47	1.77	2.17	24.42	1.64	1.21
Sep 2025	42.23	0.84	37.18	0.37	1.81	2.77	20.22	2.21	1.63
Dec 2025	43.49	0.78	38.41	0.53	1.75	3.08	15.58	2.59	1.91
Mar 2026	54.68	0.6	50.56	1.73	1.73	3.52	15.62	2.97	2.19
Jun 2026	43.85	0.64	39.07	0.86	1.74	3.26	22.39	2.53	1.87

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	78	4	73	1	2	0	-267	0	0.46
Mar 2016	67	4	62	1	2	1	32	0	0.48
Mar 2017	82	4	71	0	2	6	19	5	4.91
Mar 2018	112	3	95	2	2	14	27	10	8.89
Mar 2019	123	1	105	4	2	18	31	12	10.28
Mar 2020	117	1	99	2	2	17	26	12	10.04
Mar 2021	110	2	90	1	3	17	25	12	10.22
Mar 2022	115	2	91	2	6	18	18	15	12.2
Mar 2023	138	3	113	2	6	17	13	15	11.86
Mar 2024	172	6	145	2	7	17	21	13	10.46
Mar 2025	151	4	134	6	7	13	26	9	7.43
Mar 2026	179	4	159	3	7	12	19	9	6.94
TTM	184	3	165	3	7	13	—	10	7.6

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	40.46%
FIIs	0.07%
DIIs	0.4%
Government	0.05%
Public	59.01%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Sep 2023	43.21%	0.22%	0.2%	0%	56.38%
Dec 2023	43.21%	0.22%	0.67%	0%	55.9%
Mar 2024	43.21%	0.12%	0.99%	0%	55.69%
Jun 2024	42.99%	0.06%	1.17%	0%	55.78%
Sep 2024	42.99%	0.06%	1.17%	0%	55.79%
Dec 2024	42.99%	0.06%	0.87%	0.06%	56.04%
Mar 2025	43.16%	0.12%	0.69%	0.06%	55.99%
Jun 2025	40.46%	0%	0.64%	0.05%	58.83%
Sep 2025	40.46%	0.05%	0.59%	0.05%	58.84%
Dec 2025	40.46%	0.02%	0.44%	0.05%	59.02%
Mar 2026	40.46%	0.1%	0%	0.05%	59.39%
Jun 2026	40.46%	0.07%	0.4%	0.05%	59.01%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	10	8	21	31	69	20	0	0	49	69
Mar 2016	10	8	19	23	60	19	0	0	41	60
Mar 2017	11	16	18	29	73	19	0	0	54	73
Mar 2018	12	63	14	28	118	25	0	0	92	118
Mar 2019	12	75	12	38	137	24	15	0	97	137
Mar 2020	12	110	11	43	176	34	40	2	100	176
Mar 2021	12	122	19	39	192	90	0	2	101	192
Mar 2022	12	136	26	52	226	92	0	2	131	226
Mar 2023	13	181	26	57	277	92	0	4	180	277
Mar 2024	13	196	30	55	294	91	0	8	195	294
Mar 2025	13	205	27	48	293	86	0	8	199	293
Mar 2026	14	266	38	44	362	84	0	8	270	362

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-3	0	3	0
Mar 2016	6	-1	-5	0
Mar 2017	4	-2	-1	0
Mar 2018	-5	-8	33	20
Mar 2019	4	-15	-4	-14
Mar 2020	12	-39	21	-6
Mar 2021	13	-18	6	1
Mar 2022	5	-8	4	1
Mar 2023	-4	-8	28	17
Mar 2024	0	-9	3	-6
Mar 2025	-3	-2	-7	-11
Mar 2026	-29	-3	60	28

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	124	87	114	126	129	137	165	193	159	102	141	132
Inventory Days	95	95	102	77	67	85	28	188	230	237	274	258
Days Payable	187	160	165	118	134	160	161	291	232	152	182	138
Cash Conversion Cycle	32	22	51	85	62	62	32	91	157	188	234	252
Working Capital Days	7	3	34	89	116	139	130	146	151	117	186	197
ROCE %	12%	12%	24%	25%	20%	15%	13%	12%	11%	10%	7%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of MEDICAMEN BIOTECH LIMITED (MEDICAMEQ)?

The reported market capitalisation for MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) is ₹386Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MEDICAMEQ?

The current price shown for MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) on Fincrux is ₹284 with a 52-week high/low of ₹454/210.

What is the P/E ratio of MEDICAMEN BIOTECH LIMITED (MEDICAMEQ)?

The stock P/E for MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) is 37.5 on Fincrux, with ROE at 3.78% and ROCE at 5.50%.

What were MEDICAMEQ latest quarterly results?

For Jun 2026, MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) reported sales ₹43.85 Cr and net profit ₹2.53 Cr (figures in ₹ crore unless noted).

What are MEDICAMEQ annual sales and net profit?

For TTM, MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) shows sales of ₹184 Cr and net profit of ₹10 Cr on the Fincrux profit & loss statement.

Who owns MEDICAMEN BIOTECH LIMITED (MEDICAMEQ)?

Latest shareholding for MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) on Fincrux: Promoters 40.46% (Jun 2026), FIIs 0.07% (Jun 2026), DIIs 0.40% (Jun 2026), Government 0.05% (Jun 2026), Public 59.01% (Jun 2026).

Where can I find MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) financials?

MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MEDICAMEQ balance sheet and cash flow?

Yes. The MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 15:25